Open AccessA nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer
Author(s) -
N. Cheng,
R. Watkins-Schulz,
R.D. Junkins,
C.N. David,
B.M. Johnson,
S.A. Montgomery,
Kellie Peine,
D.B. Darr,
Hongxue Yuan,
K.P. McKin,
Q. Liu,
L. Miao,
L. Huang,
Eric M. Bachelder,
Kristy M. Ainslie,
J.P.-Y. Ting
Publication year - 2018
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/qxx5-vq40
Subject(s) - sting , activator (genetics) , triple negative breast cancer , breast cancer , immunity , cancer research , immune system , immunology , medicine , cancer , physics , receptor , thermodynamics